Two new articles – co-authored by DruGS program members Duane Duncan and David Moore – analyse how gender is handled in Australian government policy documents on alcohol and violence in the night-time economy. The articles are based on an analysis of 18 publicly accessible national, state and territory government alcohol policies, strategies and related supporting…
The term ‘take-home naloxone’ refers to a variety of life-saving initiatives in which a medication (naloxone) is made available to non-medically trained people for administration to others experiencing an opioid overdose. Despite a range of efforts to expand these initiatives over the last decade, the uptake of take-home naloxone in Australia remains inconsistent. This month…
In early 2021 the Commonwealth Department of Health funded researchers at La Trobe University to conduct a study on telehealth for hepatitis C treatment during COVID-19 Understanding experiences of telehealth care delivery for hepatitis C treatment in Australia. Telehealth has been successful in the treatment of hepatitis C by improving patient access to healthcare, especially…
In 2019 the DruGS team completed work on two large Australian Research Council-funded qualitative projects, one on opioid overdose and take-home naloxone, and the other on performance and image enhancing drugs and hepatitis C. In an invited chapter for the forthcoming Handbook on Intoxicants and Intoxication edited by Tamar Antin, Vibeke Frank and Geoffrey Hunt,…
Two new articles, co-authored by DruGS program members David Moore and Duane Duncan, analyse how gender issues are handled in recent Australian research on alcohol and violence. Both articles report findings from an international comparative research project involving colleagues from universities in Australia, Canada and Sweden, and funded by the Australian Research Council. The first…
This year we began an exciting new project on people’s experiences of hepatitis C, treatment and post-treatment life in this new age in which hepatitis C elimination seems possible. This project will generate new knowledge on impediments to hepatitis C treatment uptake and a publicly accessible website presenting personal experiences of treatment, decision-making about treatment,…
The public health challenge of hepatitis C may become a thing of the past with the advent of new drugs for the treatment of hepatitis C. These drugs have been heralded as ‘revolutionary’, having the potential to both eliminate hepatitis C and transform the lives of people affected by it. Australia has committed to eliminating…
In 2019 the DruGS team completed work on a qualitative interview-based research project on stigma, conducted with South Western Sydney Drug Health Services. Two journal articles were written from the project and have now been published. The first article was recently accepted for publication in Sociology of Health and Illness. Entitled ‘Exclusion and hospitality: The…
In June DruGS Program Lead Professor Suzanne Fraser took part in a webinar entitled Love from a distance: Sex, intimacy and technology. Hosted by the Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University, the webinar explored the role of new technologies in shaping sexuality and intimacy, issues that have been…
Treatment of hepatitis C has been revolutionised in recent years with the introduction of interferon-free direct-acting antiretroviral (DAA) medications. With far fewer side effects and higher success rates than past treatments, hepatitis C elimination has been adopted in Australia and elsewhere as an important public health goal. Reaching all those affected by hepatitis C, informing…
DruGS 
You must be logged in to post a comment.